A fintech-meets-workforce company that pays down clinicians' student loans so hospitals can finally keep them. Think ROTC, but the service is patient care.
Somewhere in a hospital HR office this quarter, a new graduate is signing a job offer. Nothing unusual there. What is unusual is the second number on the page: not just a salary, but a promise to chip away at the student loans she spent four years accumulating. That promise is the whole business of Clasp.
Clasp is a Boston company that sells health systems something they have wanted for a decade and rarely gotten - clinicians who show up, and then stay. It does this by rewiring the oldest lever in employment: who pays for the training. Instead of recruiters chasing nurses and therapists after graduation with signing bonuses, Clasp gets employers to commit earlier and pay later, in the form of student loan repayment tied to how long someone stays.
It is, depending on your mood, either a clever piece of financial engineering or a quietly radical idea about who should be on the hook for the cost of becoming a clinician. Clasp would happily take either description.
Healthcare has a staffing problem that no amount of pizza in the break room has fixed. Turnover is high, contract labor is expensive, and the people leaving are often the ones a hospital spent the most to recruit. Meanwhile, the clinicians themselves carry a second weight that rarely makes the org chart: student debt, the kind that decides where you work and how long you can afford to stay there.
Most people treat these as separate problems. One belongs to HR, the other to the loan servicer. Clasp's founding observation was that they are the same problem wearing two badges. Debt drives where clinicians go. Staffing gaps are what happens when they leave. Solve the first and you ease the second.
The timing helped. Federal student loan caps have been squeezing how clinicians pay for school, which makes an employer willing to cover the gap look less like a perk and more like a lifeline. Clasp sells into that anxiety, though it would prefer the word "solution."
Tess Michaels started the company in 2018 while finishing her MBA at Harvard Business School. She had the resume you would expect of someone about to argue with an entire industry - Goldman Sachs, Vista Equity Partners, a University of Pennsylvania degree - and one thing you might not: a family full of physicians. She had watched, up close, how staffing gaps strain care teams and how a loan balance quietly shapes a clinician's whole career map.
The first version of the company was called Stride Funding, and it was closer to pure fintech - financing that paid off based on outcomes rather than fixed interest. The bet underneath it never changed: that the person who benefits from your training (your employer) should help pay for it. In 2024 the company rebranded to Clasp, a name meant to evoke two hands holding on, and pointed the whole machine at healthcare.
Michaels has collected the usual founder hardware along the way - Forbes 30 Under 30, an MIT FinTech competition grand prize - but the more telling detail is that she keeps describing the recruitment system as "broken." Founders who succeed at this tend to be the ones who are genuinely annoyed.
Tess Michaels launches the company at Harvard Business School around outcomes-based education financing.
Led by Firework Ventures, with Juvo Ventures, Graham Holdings, GSV Ventures, Slow Ventures and Sinai Ventures.
Oversubscribed venture round led by Crosslink Capital; new identity by the designer behind the Instagram and Affirm logos. Focus narrows to healthcare.
Led by Crosslink Capital and Digitalis Ventures, with Juvo, Strada Education and operators Frank Britt and Jason Nazar. New health-system customers announced.
Forbes features Clasp's "ROTC for healthcare" approach to erasing clinician student debt.
Here is the mechanism. An employer commits to a student before graduation. The student agrees to a multi-year work commitment. In return, the employer repays some or all of that student's loans over the years they stay. Clasp is the platform that matches the two, manages the loan-repayment plumbing, and keeps the whole arrangement honest.
For a hospital, the math is almost suspiciously tidy: a steady pipeline of committed talent - nurses, physical and occupational therapists, radiologic technologists, respiratory therapists - without the signing bonuses, the contract-labor premiums, or the revolving door.
Commit early, repay over time, in exchange for tenure. The ROTC structure, minus the boot camp.
Connects current students and trainees to employers nationwide for hard-to-fill clinical roles.
Technology that manages employer-funded repayment tied to tenure - the boring part that makes it work.
A clever model is worth nothing if the people it touches still leave. So here is what Clasp reports, and where the argument lives or dies.
The customer list is the part that makes skeptics blink. It reads less like an early-stage pilot program and more like a ranking of places you would actually want to be treated.
Strip away the platform and the funding rounds, and Clasp is arguing for a different default. For decades, the cost of becoming a clinician has landed almost entirely on the clinician. Clasp wants to move part of that weight onto the institutions that depend on those clinicians showing up - and to make staying a financially rational decision rather than a moral one.
The backers reflect that double identity. Crosslink Capital and Digitalis Ventures lead on the venture side; SHRM and Strada Education bring the HR and education credibility. Impact investors show up because the model, if it works, reduces debt for the people doing some of society's least optional work.
Healthcare's staffing math is not getting easier. The population is aging, training pipelines are tight, and federal loan caps keep reshaping how clinicians can pay for school. Each of those pressures pushes in Clasp's direction - toward employers who are willing to put money down early to keep people longer.
Whether the 2.5x retention number holds at national scale is the open question, and an honest reader should keep it open. Self-reported figures from a Series B company are a starting point, not a verdict. But the underlying logic is hard to argue with: tie the debt relief to the tenure, and you have aligned two things that usually fight.
Return to that HR office. The graduate signs. The salary is real, but so is the line underneath it - the loans that will shrink a little every month she stays. She is not being bribed to show up. She is being given a reason to stay. Clasp built a company on the difference between those two things.